Michael Khan
Director Ejecutivo en Argonaute RNA Ltd. .
Cargos activos de Michael Khan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HEART UK | Corporate Officer/Principal | - | - |
| Diabetes UK | Corporate Officer/Principal | - | - |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Director Ejecutivo | 01/01/2021 | - |
Historial de carrera de Michael Khan
Antiguos cargos conocidos de Michael Khan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SILENCE THERAPEUTICS PLC | Director/Miembro de la Junta | 19/09/2012 | 17/06/2016 |
| Director Técnico/Científico/I+D | 19/09/2012 | 17/06/2016 | |
| University of Warwick | Corporate Officer/Principal | - | - |
Formación de Michael Khan.
| University College London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 7 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Commercial Services | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Empresas privadas | 3 |
|---|---|
| HEART UK | |
| Diabetes UK | |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Khan
- Experiencia
